CASE: arbitration ; pharma R&D
John Liebeskind assisted a Middle-Eastern pharmaceutical group in an arbitration resulting from the revocation of its contract for the research and development (R&D) of a new drug with a foreign developer. Although the arbitration tribunal ruled that the principal had been at fault, it reduced the multi-million quantum by 80% on the basis of John’s …